Boehringer Ingelheim and Enara Bio join forces to develop new Cancer Immunotherapies
Boehringer Ingelheim and Enara Bio reported that they have entered into a strategic partnership and licensing agreement to study and
Read moreBoehringer Ingelheim and Enara Bio reported that they have entered into a strategic partnership and licensing agreement to study and
Read moreThe CELLAVISTA® 4 is a cutting-edge automated ultrahigh-throughput imaging system able to scan a 96 well microplate at 10X magnification
Read moreUtilising Surface Plasmon Resonance (SPR) analysis for drug development or drug discovery can make a big impact. SPR analysis can
Read moreImproving half-life and cell penetration in a peptide identified to efficiently interact with a newly discovered intracellular pathway. A Copexis
Read morePfizer and BioNTech have announced their mRNA-based vaccine candidate for COVID-19, tested in a Phase 3 study involving 43,538 participants,
Read moreFully Integrated Drug Development Consulting: CMC, Clinical, Toxicology and Regulatory Support A Copexis Case Study Virtual Integrated Development: a paradigm
Read morePhenomic AI, a Canadian biotechnology company that uses an AI/ML platform for targeting the tumor stroma, has launched with $6
Read moreEnzolytics, Inc, a drug development company with a focus on debilitating infectious diseases, announced on September 16, the execution of
Read moreSanofi and GlaxoSmithKline are close to reaching a 500 million-pound ($624 million) deal to supply the United Kingdom government with
Read moreAbbVie, Harbour BioMed, Utrecht University and the Erasmus Medical Center (EMC) revealed today they have entered into a partnership to
Read more